Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 833,802
- Share change
- -90,983,584
- Total reported value
- $2,716,547
- Price per share
- $3.20
- Number of holders
- 2
- Value change
- -$68,395,020
- Number of sells
- 44
Report period
Q3 2023
Institutions
2
Top holders
2
OCX full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
176%
|
50,181,335
|
$11,541,707 | — | 30 Jun 2023 | |
| AWM Investment Company, Inc. |
13F
|
Company |
50%
|
14,185,664
|
$3,262,703 | — | 30 Jun 2023 | |
| PURA VIDA INVESTMENTS, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
48%
|
13,625,022
|
$3,133,755 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
15%
|
4,359,202
|
$1,002,616 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
9.8%
|
2,790,933
|
$641,915 | — | 30 Jun 2023 | |
| Defender Capital, LLC. |
13F
|
Company |
8.2%
|
2,327,930
|
$535,113 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.3%
|
1,228,553
|
$282,567 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
1,212,026
|
$278,766 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
337,765
|
$77,686 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.99%
|
281,845
|
$64,824 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.88%
|
251,952
|
$57,949 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
194,911
|
$44,829 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.48%
|
138,100
|
$32,000 | — | 30 Jun 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.45%
|
127,459
|
$29,316 | — | 30 Jun 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.23%
|
65,123
|
$15,000 | — | 30 Jun 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.18%
|
51,165
|
$11,768 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.17%
|
49,797
|
$11,453 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.16%
|
44,700
|
$10,281 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
43,723
|
$10,057 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
42,197
|
$9,705 | — | 30 Jun 2023 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
0.14%
|
40,500
|
$9,315 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
34,201
|
$7,866 | — | 30 Jun 2023 | |
| Merit Financial Group, LLC |
13F
|
Company |
0.11%
|
32,000
|
$7,360 | — | 30 Jun 2023 | |
| LEE DANNER & BASS INC |
13F
|
Company |
0.1%
|
27,763
|
$6,000 | — | 30 Jun 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.1%
|
27,321
|
$6,000 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.09%
|
24,450
|
$5,622 | — | 30 Jun 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.07%
|
19,700
|
$4,531 | — | 30 Jun 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.06%
|
16,422
|
$3,777 | — | 30 Jun 2023 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.05%
|
14,776
|
$3,398 | — | 30 Jun 2023 | |
| Williams Jones Wealth Management, LLC. |
13F
|
Company |
0.05%
|
15,000
|
$3,450 | — | 30 Jun 2023 | |
| Creative Planning |
13F
|
Company |
0.04%
|
12,136
|
$2,791 | — | 30 Jun 2023 | |
| LEVIN CAPITAL STRATEGIES, L.P. |
13F
|
Company |
0.04%
|
10,500
|
$2,415 | — | 30 Jun 2023 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.04%
|
10,000
|
$2,300 | — | 30 Jun 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
4,164
|
$958 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
3,345
|
$1,000 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
3,104
|
$714 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,323
|
$304 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,125
|
$259 | — | 30 Jun 2023 | |
| Riggs Asset Managment Co. Inc. |
13F
|
Company |
0%
|
1,000
|
$230 | — | 30 Jun 2023 | |
| Piscataqua Savings Bank |
13F
|
Company |
0%
|
500
|
$115 | — | 30 Jun 2023 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
500
|
$115 | — | 30 Jun 2023 | |
| Coppell Advisory Solutions LLC |
13F
|
Company |
0%
|
205
|
$44 | — | 30 Jun 2023 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
195
|
$45 | — | 30 Jun 2023 | |
| ALBION FINANCIAL GROUP /UT |
13F
|
Company |
0%
|
152
|
$35 | — | 30 Jun 2023 | |
| Lindbrook Capital, LLC |
13F
|
Company |
0%
|
86
|
$20 | — | 30 Jun 2023 | |
| Avior Wealth Management, LLC |
13F
|
Company |
0%
|
15
|
$3 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
10
|
$2 | — | 30 Jun 2023 | |
| John Peter Gutfreund |
3/4/5
|
Former Director |
—
mixed-class rows
|
760,000
mixed-class rows
|
$153,654 | — | 30 Jun 2023 | |
| Ronald Asbury Andrews |
3/4/5
|
Former CEO, Director |
—
mixed-class rows
|
633,212
mixed-class rows
|
$125,332 | — | 01 Dec 2022 | |
| Alfred D. Kingsley |
3/4/5
|
Director |
—
mixed-class rows
|
597,878
mixed-class rows
|
$109,143 | — | 23 Jun 2023 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q3 2023
As of 30 Sep 2023,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
833,802 shares.
The largest 2 holders included
AWM Investment Company, Inc. and Defender Capital, LLC..
This page lists
2
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
45
Q3 2023 holders
2
Holder diff
-43
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.